Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Neoplasms

Explore clinical trials studying Central Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

1,870 public trials 483 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Neoplasms trial results

Active, Not Recruiting

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

NCT01878617

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
Locations
  • Lucille Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Yale University New Haven, Connecticut, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

NCT06521567

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Iowa City, Iowa, United States
  • GSK Investigational Site Hackensack, New Jersey, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

NCT04365374

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +10 more
Locations
  • HonorHeath Scottsdale Osborn Medical Center Phoenix, Arizona, United States
  • University of Arkansas Medical Center Little Rock, Arkansas, United States
  • Ascension St. Vincent's- Riverside Jacksonville, Florida, United States
  • Baptist MD Anderson Cancer Center- Jacksonville Jacksonville, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details
Active, Not Recruiting

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

NCT04674683

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Innovative Clinical Research Institute (ICRI) Pasadena, California, United States
  • Emad Ibrahim, MD, INC Redlands, California, United States
View all 139 locations
View Trial Details

Related conditions